Weekly Aspergillosis Research Update, 26 October 2026, featuring an illustration of Aspergillus fumigatus and research on ABPA, diagnostics, antifungals and host defence.

Weekly Aspergillosis Research Update – 26 October 2026

Weekly Aspergillosis Research Update, 26 October 2026, featuring an illustration of Aspergillus fumigatus and research on ABPA, diagnostics, antifungals and host defence.
Latest aspergillosis research covering eosinophil activity in ABPA, new diagnostic methods, antifungal susceptibility and fungal host defence.

This week's research highlights new insights into eosinophil activity in allergic bronchopulmonary aspergillosis (ABPA), promising diagnostic methods for invasive aspergillosis, and experimental approaches to understanding antifungal susceptibility and host defence.

The following selection covers recent clinical and laboratory research, including peer-reviewed publications and preprints. Findings from experimental studies should not be interpreted as established changes to clinical practice.

1. Eosinophil extracellular traps and mucus plugging in ABPA

Sasaki H et al. IFN-γ-NOD2/IL-5-FCGR axis enhances eosinophil extracellular trap formation in allergic bronchopulmonary aspergillosis/mycosis. Journal of Allergy and Clinical Immunology, 20 October 2026.

Read the published study

This study investigated why eosinophils in patients with ABPA or allergic bronchopulmonary mycosis (ABPM) may contribute to the formation of the characteristic tenacious mucus plugs found in affected airways.

Using transcriptomic and proteomic analyses, the researchers compared eosinophils from patients with ABPA/M, eosinophilic asthma and healthy controls. They identified interacting inflammatory pathways involving interferon-gamma (IFN-γ), IL-5 and NOD2-related signalling that enhanced IgG-triggered eosinophil extracellular trap formation.

These extracellular traps contain DNA and cellular material released by eosinophils and may contribute to mucus plugging. The investigators also identified changes in ICAM-1, PD-L1 and Fc gamma receptor expression associated with eosinophil activation.

Clinical significance: The findings provide a more detailed mechanistic explanation for eosinophil-associated airway pathology in ABPA. They support further investigation of inflammatory pathways involved in mucus plugging, although the study does not establish a new therapeutic intervention.

2. New galactomannan chemiluminescence assay for invasive aspergillosis

Xiao Y et al. A novel Aspergillus galactomannan chemiluminescence immunoassay: Evaluation for diagnosis of invasive pulmonary aspergillosis in a multicenter controlled study. Medical Mycology, 21 October 2026.

Read the published study

This multicentre retrospective study evaluated a chemiluminescence immunoassay (GM-CLIA) for detecting Aspergillus galactomannan antigen in serum and bronchoalveolar lavage fluid (BALF).

The evaluation included 246 serum and 228 BALF samples from patients with and without invasive aspergillosis.

  • Serum sensitivity: 93.97%
  • Serum specificity: 97.46%
  • BALF sensitivity: 93.58%
  • BALF specificity: 95.76%

Results correlated strongly with the established galactomannan enzyme immunoassay.

Clinical significance: Chemiluminescence testing may offer an efficient alternative laboratory method for galactomannan detection. The promising diagnostic performance requires prospective validation, particularly across different clinical populations and disease-risk groups.

3. Disrupting septin function increases susceptibility to caspofungin

Busch RJ et al. Deletion of core septin gene aspB in Aspergillus fumigatus results in fungicidal activity of caspofungin. Molecular Biology of the Cell, 26 October 2026.

Read the published study

Echinocandins such as caspofungin are generally fungistatic rather than reliably fungicidal against Aspergillus fumigatus.

This experimental study examined septins, structural proteins involved in fungal cell organisation and responses to cell-wall stress.

Deletion of the septin gene aspB increased susceptibility to caspofungin and reduced fungal viability following treatment. In a neutropenic mouse model of invasive aspergillosis, caspofungin treatment improved survival and reduced fungal burden in animals infected with the mutant strain.

Proteomic analyses also identified candidate proteins associated with septin-dependent responses to cell-wall stress.

Clinical significance: The study identifies fungal stress-response mechanisms that could potentially be targeted to improve echinocandin activity. However, genetic deletion in experimental strains does not demonstrate that an equivalent therapeutic strategy is currently feasible in patients.

4. Ribosome biogenesis and fungal survival during host stress

Adeoye JA et al. Ribosomal biogenesis factor links ribosome homeostasis to host relevant stress survival in Aspergillus fumigatus. bioRxiv, 26 October 2026. Preprint.

Find the preprint in Europe PMC

This research examines the role of the ribosome biogenesis factor BFR2 in maintaining fungal cellular function and surviving stresses encountered during infection.

Experimental depletion of BFR2 was associated with impaired stress tolerance and reduced survival during host immune interactions, suggesting a connection between ribosome homeostasis and fungal pathogenicity.

Research significance: The findings suggest that ribosome biogenesis and its associated stress-response pathways deserve further investigation as potential antifungal targets.

Evidence status: Preprint; not yet peer reviewed.

5. Macrophage oxidative responses restrict Aspergillus growth

Goins ML et al. Macrophage PHOX restricts Aspergillus fumigatus germination and hyphal development through ROS-dependent immunity. bioRxiv, 19 October 2026. Preprint.

Read the preprint

This experimental study investigates the contribution of phagocyte NADPH oxidase (PHOX) and reactive oxygen species to macrophage-mediated control of Aspergillus fumigatus.

It focuses on the ability of macrophages to restrict fungal germination and hyphal development, processes central to early host defence against invasive aspergillosis.

Research significance: Understanding how macrophages control distinct stages of fungal development may help clarify susceptibility to invasive infection and identify additional host-defence mechanisms for future investigation.

Evidence status: Preprint; not yet peer reviewed.

6. Eosinophilic inflammation and type 2 pathways in bronchiectasis

Liang L et al. Eosinophilic and type 2 inflammation in bronchiectasis: from phenotype recognition toward endotype-informed therapy. Frontiers in Medicine, October 2026. Review.

Read the open-access review

Although bronchiectasis has traditionally been associated with predominantly neutrophilic inflammation, a subgroup of patients exhibits eosinophilic and type 2 inflammatory characteristics.

This review examines the evidence for these phenotypes and considers their implications for more individualised treatment approaches.

Clinical significance: The review provides useful context for understanding inflammatory heterogeneity in bronchiectasis and the relationship between bronchiectasis, asthma and ABPA. It also highlights the need to distinguish bronchiectasis-associated eosinophilia from established ABPA when considering targeted treatment.

Additional research of interest

Antifungal resistance surveillance in China

Wang H et al. Antifungal resistance landscapes in major fungal pathogens in Zhejiang, China. Fungal Biology and Biotechnology, 22 October 2026.

Read the study

This regional surveillance study contributes to understanding the distribution of antifungal resistance among clinically important fungi. Such surveillance is important for detecting emerging resistance patterns, although regional findings cannot automatically be generalised to other healthcare settings.

Invasive tracheobronchial aspergillosis without classic immunosuppression

Nguyen-Cong HA et al. Bronchoscopic phenotypes and anatomical airway involvement in invasive tracheobronchial aspergillosis without classic immunosuppression: association with in-hospital mortality. Infectious Diseases, 22 October 2026.

Read the study

This study examines bronchoscopic patterns and airway involvement in patients with invasive tracheobronchial aspergillosis who lack conventional immunosuppressive risk factors. It highlights the importance of recognising invasive Aspergillus disease beyond traditionally defined high-risk populations.

Early invasive aspergillosis following liver transplantation

Zhang Y et al. Early invasive aspergillosis after liver transplantation: A matched case-control analysis of clinical features and risk factors in a Chinese cohort. International Journal of Infectious Diseases, 24 October 2026.

Read the study

This study investigates clinical characteristics and risk factors associated with early invasive aspergillosis after liver transplantation, a setting in which timely recognition and risk assessment are particularly important.

Does increased testing influence reported invasive aspergillosis incidence?

Choi CJ et al. Temporal trends in invasive pulmonary aspergillosis among critically ill patients: Serum galactomannan testing intensity and host risk status. International Journal of Infectious Diseases, 20 October 2026.

Read the study

This study examines trends in invasive pulmonary aspergillosis alongside changes in serum galactomannan testing and host risk characteristics.

Clinical significance: Changes in diagnostic testing intensity should be considered when interpreting reported trends in invasive aspergillosis, since observed case numbers may reflect both underlying disease burden and changes in detection.

Summary for clinical practice and research

Three developments are particularly noteworthy this week:

  • ABPA pathophysiology: New evidence connects inflammatory signalling pathways with eosinophil extracellular trap formation, potentially contributing to mucus plugging.
  • Diagnosis: A multicentre evaluation suggests promising performance for a chemiluminescence-based galactomannan assay, although further validation is needed.
  • Antifungal research: Studies of septins, ribosome biogenesis and macrophage oxidative responses identify mechanisms that may inform future antifungal and host-directed strategies.

These studies advance understanding of aspergillosis but do not, individually, establish changes to current diagnostic or treatment guidelines.

Prepared for the National Aspergillosis Centre professional research updates. This summary is intended for education and research awareness and should be interpreted alongside the original publications and current clinical guidance.

Further information from the National Aspergillosis Centre

Explore our related information hubs for background on the conditions, diagnostic methods and treatments discussed in this week's research:

  • ABPA Hub – allergic inflammation, eosinophils, mucus plugging and biologic treatments.
  • Diagnostics & Monitoring Hub – galactomannan testing, fungal diagnostics and monitoring.
  • Antifungals Hub – antifungal medicines, resistance, monitoring and emerging treatments.
  • Immune System Hub – host defence, inflammatory pathways and immune responses to Aspergillus.
  • Research Hub – new developments in aspergillosis diagnosis, treatment and research.
  • Updates for Professionals – further research summaries, clinical evidence and professional resources.

The Thursday Sessions autumn banner featuring a steaming mug, notebook and smartphone overlooking an autumn landscape.

Thursday Sessions: Living with complexity: healthcare, technology and keeping control

The Thursday Sessions autumn banner featuring a steaming mug, notebook and smartphone overlooking an autumn landscape.
The Thursday Sessions: sharing experiences, practical advice and mutual support for people living with aspergillosis.

Thursday Patient Discussion — 29 October 2026

Our Thursday discussion covered a wide range of subjects, from managing medicines and communicating with healthcare professionals to artificial intelligence, digital security and the growing complexity of everyday life.

Although these subjects might initially seem unrelated, a common theme emerged: living with a long-term condition already requires considerable effort, and the systems intended to help us do not always make life easier.

The discussion also highlighted how valuable it can be to share experiences, learn from one another and discover practical ways of reducing that burden.

1. Managing medicines: balancing benefits and side effects

Several participants expressed concerns about taking multiple medicines, particularly blood pressure treatments and statins.

Medicines can provide important benefits, but side effects, interactions and the practical demands of taking several treatments can affect everyday life.

This is especially relevant for people with aspergillosis who may also be taking antifungal medicines, steroids, inhalers or treatments for other conditions.

Some antifungal medicines can interact with statins and other commonly prescribed drugs. The risks depend on the particular combination.

What may help

  • Ask your GP or pharmacist for a medication review, particularly if you take several medicines.
  • Keep an up-to-date list of all prescribed medicines, over-the-counter products and supplements.
  • Explain how suspected side effects affect your daily life, not just what symptoms you experience.
  • Ask whether each medicine is still needed, whether alternatives exist and what monitoring is appropriate.
  • Do not stop or change prescribed medicines without discussing the risks and benefits with your healthcare professional.

A structured medication review offers an opportunity to consider treatment benefits, side effects, interactions and individual preferences together.

2. When navigating healthcare becomes exhausting

Participants described how difficult it can be to explain a complicated medical history repeatedly, particularly when seeing unfamiliar doctors or attending A&E.

Problems with continuity of care and accessing the same GP were also raised.

For someone already coping with fatigue or illness, having to coordinate appointments, explain previous decisions and advocate for themselves can become another substantial burden.

There was a strong sense that patients want healthcare professionals to understand how illness affects their lives, rather than relying entirely on test results or individual symptoms.

What may help

  • Prepare a short medical summary containing your diagnoses, current medicines, allergies and important treatment history.
  • Keep copies of significant clinic letters and relevant test results where possible.
  • Before an appointment, identify the two or three issues you most need to discuss.
  • Consider taking a trusted family member, friend or carer to important consultations.
  • Ask whether your GP practice can help improve continuity or coordinate care between services.

It is also reasonable to explain when the work of managing healthcare is itself becoming overwhelming.

3. Can artificial intelligence help?

Artificial intelligence (AI) prompted considerable discussion.

Some participants had found AI helpful in understanding information and thinking through difficult questions. Others were concerned about reliability, privacy and the possibility that technology is becoming too complicated.

AI can be useful for explaining unfamiliar terminology, preparing questions for appointments, summarising general information or helping people organise their thoughts.

However, AI systems can also produce incorrect or misleading answers, including answers that sound convincing.

Using AI more safely

  • Use AI to help understand information, not to replace clinical assessment.
  • Check important medical claims against reliable sources such as the NHS, specialist clinical teams and established patient information services.
  • Ask AI to explain uncertainty and identify where further evidence is needed.
  • Avoid entering identifiable medical records, financial details or other sensitive personal information unless you understand how the service handles and protects that data.
  • Discuss treatment decisions with an appropriate healthcare professional.

AI may be most helpful when it makes information easier to understand and reduces the effort required to prepare for a conversation with a clinician.

4. Digital technology: useful tools, genuine concerns

The conversation moved into wider concerns about scams, banking security, smartphone applications and the pace of technological change.

Fraud is a real problem, and digital technology can be exploited by criminals. However, it is important to distinguish between what has actually happened and possible explanations that have not been established.

For example, unauthorised card payments do not necessarily mean that someone has gained access to a phone. Stolen card details and compromised online accounts are different forms of fraud.

Practical precautions

  • Install apps from official app stores and check who publishes them.
  • Keep your phone and apps updated.
  • Be cautious about unexpected links, attachments and requests to install remote-access software.
  • Use strong, unique passwords and enable two-factor authentication where available.
  • Never share one-time banking security codes with someone who contacts you unexpectedly.
  • If you suspect banking fraud, contact your bank immediately using its official contact details.

There is no need to understand every technical aspect of digital fraud to take sensible precautions.

5. Technology that genuinely helps patients and carers

The discussion also identified positive uses of technology, particularly apps that help carers coordinate responsibilities and share information.

Useful functions may include medication reminders, shared calendars, appointment lists, care notes and organising help from family members.

The NHS App may also allow an authorised family member or carer to help manage another person's GP services through formal family and carer access, sometimes called proxy access.

This can be safer than sharing passwords because access is arranged through the GP practice, with appropriate safeguards.

Before choosing an app, consider whether it genuinely solves a problem, how easy it is to use and who can access the information stored within it.

The best technology is not necessarily the most sophisticated. It is the technology that makes life easier without introducing unnecessary complexity.

6. Sharing experiences without increasing anxiety

One of the strengths of peer-support meetings is that participants can speak openly, share experiences and discover that others have faced similar difficulties.

Sometimes, however, discussion of uncertain risks can lead to increased worry.

It can help to distinguish three things:

  • What someone has personally experienced.
  • What might explain that experience.
  • What is supported by reliable evidence.

Being cautious is sensible, but we should not feel that every possible technological risk is an immediate threat.

What did we learn?

The discussion illustrated that managing a long-term illness involves much more than understanding the disease itself.

Patients and carers must navigate medicines, appointments, information, technology, security and sometimes conflicting advice. These responsibilities can be particularly difficult when people are already fatigued or unwell.

Three messages stood out:

People need to feel heard. Their everyday experience and quality of life matter alongside clinical measurements.

Information should empower, not overwhelm. More information is not automatically better if it creates additional work or uncertainty.

Support should make life easier. Whether it comes from a clinician, a carer, a digital tool or a patient community, its value lies partly in reducing the burden on the person who needs help.

Useful resources

Medicines and medication reviews

Managing healthcare and supporting carers

Online safety and fraud

Aspergillosis information and support

Continuing the conversation

We would welcome further thoughts from participants, particularly on these questions:

  1. What makes dealing with healthcare more difficult than it needs to be?
  2. Have you found an app, AI tool or other resource that genuinely makes managing illness or caring for someone easier?
  3. What could healthcare professionals do to reduce the effort patients spend coordinating their own care?

You do not need to be technically confident or medically knowledgeable to contribute. Personal experiences and practical suggestions are equally valuable.


This summary reflects themes discussed during an informal patient-support meeting. It does not represent a formal survey or imply that every participant shared the same views. The practical information is general guidance, not individual medical advice.


Patients, advocates, clinicians and researchers taking part in a respiratory health panel discussion.

Patient voices at the ERS Congress: watch the ELF recordings

Patients, advocates, clinicians and researchers taking part in a respiratory health panel discussion.
Patient-centred sessions at the ERS Congress brought lived experience into conversations about respiratory research and care.

What can respiratory care learn from the people who live with lung conditions every day? At the 2026 European Respiratory Society (ERS) Congress in Barcelona, patient-centred sessions brought patients, advocates, clinicians and researchers together to discuss lived experience, research and the practical changes that can make care more responsive.

The European Lung Foundation (ELF) has gathered recordings and information from several of these sessions. They cover a wide range of issues, from the emotional and social effects of lung disease to how patients can help shape research and care.

Highlights from the sessions

  • Holistic approaches in lung disease: addressing physical, emotional and social factors
    Living with lung disease can affect much more than breathing. This discussion explored the impact on emotional wellbeing, social interaction and everyday life, and the value of looking at the whole person. Lisa McNeil, from the Aspergillosis Patient Advisory Group, joined the session as a panellist.
  • Meaningful patient involvement in research
    Patients can help researchers identify important questions, choose outcomes that matter and design studies around people’s real experiences. This session explored why involvement is most useful when it begins early and continues throughout the research process.
  • Breathing easy: addressing air, housing and poverty in patient care
    Where people live and the conditions in their homes can affect respiratory health. This session considered how air quality, housing and poverty can combine to create challenges, and why these wider circumstances need to be part of conversations about care.
  • Invisible burdens: the stigma of lung conditions
    Coughing, breathlessness and assumptions about the causes of lung disease can lead to misunderstanding or stigma. The discussion highlighted the importance of listening to patients, using respectful language and treating people with empathy and dignity.
  • The power of patient partnerships
    Patients and professionals explored how to work together in research, education and care. Topics included co-creating digital and self-management tools, involving patients in long-term studies, and building partnerships within respiratory organisations.

These recordings show patients contributing as partners: bringing their experience into discussions about research priorities, healthcare tools, stigma and the support people need. They also give a glimpse of the conversations taking place across the respiratory community in Europe.

Explore the ELF recordings and patient-centred content from the 2026 ERS Congress


Patients, clinicians and researchers sharing ideas as partners at a respiratory health meeting.

Patients and professionals working together at ERS

Patients, clinicians and researchers sharing ideas as partners at a respiratory health meeting.
Patient experience can help shape respiratory research, education and care.

Patients bring an essential perspective to respiratory research and care. Their experience can help researchers understand which questions matter, what outcomes make a difference in daily life, and how information and support can better meet people’s needs.

At the 2026 European Respiratory Society (ERS) Congress in Barcelona, patient partnership was a central theme. Sessions explored how patients and professionals can work together in research, education and care.

The symposium The Power of Patient Partnerships covered the foundations of patient–professional partnerships, co-creating digital and self-management tools, involving patients in long-term studies, and the role of patient partnership in bronchiectasis. A separate patient-centred session explored meaningful patient involvement in research.

Members of our patient group were involved in the Congress too. At least two members contributed as speakers or panellists at the ELF Patient Organisation Networking Day, and we presented a poster about our patient engagement work. The Networking Day was an invitation-only event, but related ERS sessions are available to watch online.

These discussions show how patient experience can contribute to research and care, and how patient organisations can share ideas and learn from one another across Europe.


ERS learning resources on pulmonary aspergillosis

The European Respiratory Society (ERS) Respiratory Channel has a useful collection of talks and case-based teaching on pulmonary aspergillosis. The sessions cover the different clinical forms of disease, including allergic bronchopulmonary aspergillosis (ABPA), chronic pulmonary aspergillosis (CPA) and invasive aspergillosis.

Topics include the clinical spectrum of pulmonary aspergillosis, selecting and interpreting diagnostic tests, antifungal treatment and its challenges, and managing complex cases. There are also case-based workshops on ABPA and CPA, and discussion of co-infection with non-tuberculous mycobacteria.

The material may be useful to respiratory clinicians, infection specialists, trainees and other healthcare professionals seeking further learning in this area. The collection brings together talks from different ERS courses and congresses; access conditions vary, and some content may require registration.

Browse ERS Respiratory Channel resources on aspergillosis


Patients and respiratory researchers seated together in discussion as equal partners.

Expertise shared across borders: an ABPA case discussion

Patients and respiratory researchers seated together in discussion as equal partners.
Patients’ experience can help shape respiratory research and the questions it seeks to answer.

Respiratory care depends on both specialist knowledge and an understanding of what matters to the people living with lung conditions. Two sessions from the 2026 European Respiratory Society (ERS) Congress show these perspectives coming together: one explores a complex case of allergic bronchopulmonary aspergillosis (ABPA), while the other focuses on meaningful patient involvement in research.

ABPA: experts discuss a complex case

Allergic bronchopulmonary aspergillosis (ABPA) is an allergic reaction to Aspergillus that can affect the lungs, often in people with asthma. Recognising it may involve bringing together a person’s symptoms, imaging and blood test results.

In this ERS Ask the Expert episode, Dr Hitasha Rupani of University Hospital Southampton and Professor Dominick Shaw of the University of Leicester are joined by Professor Eva van Braeckel of Ghent University Hospital in Belgium. They discuss the case of a 55-year-old man with asthma, a persistent cough and recurrent chest infections. His investigations show collapse and consolidation in part of the lung, bronchiectasis and widespread mucus plugging. Blood tests show raised IgE, including raised Aspergillus-specific IgE and IgG.

The specialists consider the question: how should the physician proceed? The case illustrates how clinicians draw together different findings and share expertise when assessing a complicated respiratory problem. The episode is a professional discussion, not individual medical advice or a diagnostic checklist for patients.

Watch the ERS discussion about ABPA

Patients as partners in respiratory research

Research is intended to improve people’s lives, so the experiences of patients can help make it more relevant. People living with a respiratory condition may identify questions that matter to them, explain how symptoms affect everyday life, and help researchers think about which outcomes are meaningful to patients.

A patient-centred session at the 2026 ERS Congress in Barcelona explored meaningful patient involvement in research. Chaired by Mikaela Odemyr, it featured James D. Chalmers, Charlotta Norgaard, Kjeld Hansen and Susanne Vijverberg. Its place in the Congress programme reflects the importance of partnership between patients, clinicians and researchers in respiratory health.

Patient involvement can take different forms, from helping shape research questions and study design to contributing to how findings are communicated. When it is meaningful, patients are involved as partners and their perspectives can help guide the work.

Watch the ERS session on meaningful patient involvement in research

Together, these sessions show two important parts of respiratory care: clinicians sharing specialist knowledge across countries, and patients contributing their experience to the research that may shape future care.


Illustration of older adults sharing experiences and supporting one another in a friendly group conversation

Thursday Session: Living with Aspergillosis: Finding Strength, Support and a Sense of Purpose

Thursday Conversations | 22 October 2026

Patient experiences, practical understanding and helpful resources

Illustration of older adults sharing experiences and supporting one another in a friendly group conversation
Friendship, understanding and shared experience are at the heart of our Thursday patient-support sessions.

In this week's conversation

  • Recovering confidence after respiratory infections and exacerbations.
  • Finding psychological support that understands chronic illness.
  • Adjusting to changes in independence, activity and everyday life.
  • The importance of feeling useful and helping other people.
  • Friendship, bereavement and remembering members of our community.
  • Practical information and resources to explore these subjects further.

Living with aspergillosis involves much more than managing symptoms and taking medication. It can change our confidence, independence, relationships and expectations for the future.

This week's Thursday patient-support meeting brought these experiences together in a particularly thoughtful discussion. We talked about infections and setbacks, the emotional burden of chronic illness, finding the right psychological support, keeping active within changing physical limits, and the importance of friendship.

We also took time to remember Mick and other friends who have been part of our community.

What we talked about

When illness knocks your confidence

The conversation began with experiences of prolonged chest infections, bleeding episodes and the frustration of recovery that seems to take longer than expected.

One recurring concern was how difficult it can be to regain confidence after a serious illness. Even when symptoms begin to improve, the emotional effects may linger.

Participants reflected on how frightening an exacerbation can be, particularly when it involves unfamiliar symptoms or experiences such as confusion.

These discussions reminded us that recovery is not simply a matter of improving lung function. People may also need time to rebuild confidence in their bodies and everyday activities.

Finding psychological support that understands respiratory illness

Several participants shared experiences of counselling and clinical psychology.

Some had found professional support helpful, particularly when the therapist understood the realities of living with chronic illness.

A difficulty discussed was having to explain why apparently straightforward advice might be unrealistic for someone experiencing significant breathlessness, fatigue or unpredictable exacerbations.

There was also recognition that talking with people who share similar experiences can provide something different from professional counselling.

Both forms of support have their place.

When your world becomes smaller

One of the strongest themes was the gradual loss of activities that previously gave life structure and meaning.

Employment, exercise, travelling, social activities and even ordinary household tasks can become increasingly difficult.

These changes are not simply practical inconveniences. They may affect independence, confidence and how people see themselves.

Participants described the challenge of adjusting expectations without feeling that they were giving up.

Pacing, exercise and the desire to contribute

The group discussed the difficulty of balancing activity and rest.

There can be considerable satisfaction in continuing to work, volunteer, support others or take part in patient advocacy. But worthwhile activities still require energy.

Returning to exercise after a prolonged illness was another concern. Activities that once seemed straightforward may now require much more effort.

The conversation recognised that finding a sustainable level of activity can be a continuing process of adjustment.

Why being useful matters

An important thread running through the discussion was the value of helping other people.

Sharing experience, offering reassurance and contributing to patient activities can provide a sense of purpose, particularly when illness has restricted other parts of life.

Our meetings demonstrate this regularly. Participants are not simply receiving support; they are contributing knowledge, understanding and encouragement.

Sometimes knowing that your experience has helped another person can be valuable in itself.

Remembering Mick and other friends

We also remembered Mick and other friends who have been part of our patient community.

Over time, our meetings have become more than opportunities to exchange medical information. Friendships develop, people become familiar with one another's lives, and shared experiences create lasting connections.

Losing a friend from the group can be particularly difficult. Alongside sadness and personal memories, it may bring renewed awareness of the uncertainties of living with serious illness.

Remembering those who are no longer with us is an important part of our community's history.

Their contributions, humour, friendship and encouragement remain part of what makes the group special.

Learning to manage difficult thoughts

Towards the end of the meeting, we discussed psychological approaches to managing worry and negative thinking.

Participants described techniques encountered through counselling, including the idea of carrying worries like a heavy suitcase and recognising habitual patterns of negative thinking.

The discussion explored how changing our responses to difficult thoughts may sometimes make them easier to manage.

There was also recognition that different approaches suit different people, and that friendship, conversation and humour remain important sources of support.


A closer look: understanding some of the issues raised

The following information expands on three important subjects from the discussion. It provides general educational context rather than individual medical advice.

1. Why recovery can take longer emotionally than physically

After a serious respiratory exacerbation, a person may be medically improving but still feel anxious, vulnerable or uncertain.

There are several possible reasons.

A frightening episode of breathlessness or haemoptysis may make someone more alert to changes in their breathing. Prolonged inactivity can reduce strength and stamina. Fatigue may persist, while the fear of another setback can make ordinary activities seem more daunting.

These experiences can reinforce one another. Reduced activity may contribute to loss of fitness, while loss of confidence can make restarting activity more difficult.

What may help?

Recovery should be individualised. Discuss persistent symptoms with your respiratory team, ask whether respiratory physiotherapy or pulmonary rehabilitation would be appropriate, and consider psychological support if anxiety or low mood is interfering with daily life.

For people with a history of haemoptysis, severe asthma or unstable respiratory symptoms, exercise plans should be agreed with the clinical team rather than following generic fitness advice.

Importantly, coughing up blood should never simply be dismissed as a routine feature of aspergillosis.

2. Psychological support should recognise real physical limitations

Cognitive behavioural therapy (CBT) is one approach that may help people manage anxiety, low mood and unhelpful patterns of thinking.

It explores relationships between thoughts, feelings and behaviour, and helps people develop different ways of responding to difficult situations.

However, there is an important distinction between unnecessary avoidance caused by fear and activity that is genuinely unsafe or physically beyond someone's current capacity.

Someone with severe breathlessness or a risk of haemoptysis cannot simply overcome those limitations through positive thinking.

Good psychological support should acknowledge physical illness and work alongside appropriate medical care.

It can help to explain to a therapist which limitations are medically established, which symptoms fluctuate, and what you hope to achieve.

The aim is not to deny the illness, but to reduce avoidable emotional suffering while living within its realities.

3. Maintaining purpose when life changes

Chronic illness can affect the roles through which people previously found meaning: employment, family responsibilities, hobbies, independence and social activities.

Losing or reducing these roles may affect self-esteem and identity.

One possible response is to discover different ways of contributing.

Sharing experience with newly diagnosed patients, helping organise activities, maintaining friendships or offering practical encouragement can provide opportunities for meaningful participation.

This connects with the principle of reciprocal peer support: people can benefit both from receiving support and from offering it.

However, helping others should not become another exhausting obligation. The value of someone's contribution is not determined by how much they can do.

Sometimes listening, understanding or simply being present is enough.


Helpful resources

These resources offer further information on subjects raised during the meeting.

Exercise and rehabilitation

NHS England: Pulmonary rehabilitation — Explains how individually tailored exercise and education programmes can help people with chronic respiratory disease.

Psychological wellbeing

NHS: Cognitive behavioural therapy — What CBT involves, what it may help with, and how to access treatment.

Bereavement and friendship

Cruse Bereavement Support — Information and emotional support for people experiencing grief and loss. UK helpline: 0808 808 1677.

Recognising symptoms that need urgent help

NHS: Coughing up blood — Even small amounts of blood in sputum need prompt medical advice. More than a few spots or streaks, or bleeding accompanied by breathing difficulty, chest pain or a very fast heartbeat, requires emergency assessment.

NHS: Sudden confusion — Sudden confusion or disorientation is a medical emergency. In the UK, call 999 or attend A&E.

For readers outside the UK, equivalent services and emergency arrangements will vary.


A final thought: the value of being together

Perhaps the most important message from this week's conversation was that living with aspergillosis involves continually adapting while trying to preserve the things that make life meaningful.

Health may change what we can do, but it does not remove the value of our experiences, relationships or contributions to others.

Our Thursday meetings provide an opportunity to share those experiences with people who understand. Sometimes we exchange practical information. Sometimes we discuss difficult feelings. Sometimes we laugh, remember old friends or simply enjoy one another's company.

And sometimes a conversation that begins with an everyday concern leads to something much more profound.

We may not always be able to change the illness, but we can help one another live with it.

About Thursday Conversations

These articles are based on informal discussions within our international aspergillosis patient-support community. Personal experiences are summarised without identifying participants. Additional educational information and resources are included to help readers explore the subjects discussed.

The articles are not clinical records or substitutes for individual medical advice.


Cigarette, nicotine vape, cannabis and nicotine replacement products arranged on a table with a lung illustration in the background

Smoking, Vaping and Aspergillosis: What If I Haven't Managed to Quit?

Last reviewed: 21 October 2026
Next review: 21 October 2028
Audience: People living with aspergillosis, their families and carers

Part of our series: The Questions We Don't Always Ask

Cigarette, nicotine vape, cannabis and nicotine replacement products arranged on a table with a lung illustration in the background
Smoking, vaping and cannabis raise different questions for people living with aspergillosis and other chronic lung conditions.

Perhaps you have aspergillosis and still smoke. You may have tried to stop several times, or you may feel that stopping now would make little difference because your lungs are already damaged.

Perhaps you have switched to vaping, occasionally smoke cannabis, or use another substance that you have never mentioned to your respiratory team.

You may be worried about being judged, blamed for your illness or told yet again to stop doing something you already know carries risks.

These are reasonable concerns to want to discuss.

Smoking and inhaling other substances can affect your lungs, but you deserve good healthcare, accurate information and practical support regardless of what you currently smoke or vape.

This article looks at the risks, the uncertainties and the options available, without assuming that changing an established habit is easy.

Key points

  • Smoking does not directly cause aspergillosis, but it can damage the lungs and worsen existing respiratory disease.
  • Smoking is a major cause of COPD and can aggravate asthma, bronchiectasis and other lung conditions.
  • Stopping smoking is beneficial even after many years, including when some lung damage is permanent.
  • Switching completely from cigarettes to nicotine vaping substantially reduces exposure to many harmful chemicals, but vaping is not risk-free.
  • Cannabis smoke can irritate the lungs, and cannabis plant material can sometimes contain Aspergillus spores. The evidence linking cannabis use to aspergillosis is limited, but the concern is particularly relevant to people with weakened immune systems.
  • Other smoked or inhaled substances can also cause serious lung injury.
  • Nicotine dependence can be treated. Support is available even if you are not ready to stop.
  • You can ask questions about smoking, vaping or recreational substances without needing to disclose personal details in a public discussion.

Does smoking cause aspergillosis?

Aspergillosis is caused by infection with, or an immune response to, Aspergillus fungi. Smoking is not itself a direct cause of aspergillosis.

However, tobacco smoke can damage the airways, interfere with mucus clearance and contribute to long-term inflammation. Some forms of aspergillosis occur more readily in people whose lungs are already damaged.

For example, chronic pulmonary aspergillosis (CPA) can develop in people with pre-existing structural lung disease, including COPD and previous tuberculosis.

This means smoking may contribute indirectly to some of the circumstances in which aspergillosis develops. It does not mean that smoking caused an individual person's aspergillosis.

Many people with aspergillosis have never smoked.

What if I also have COPD, bronchiectasis or asthma?

Several respiratory conditions can overlap with aspergillosis. Smoking may make their symptoms more difficult to manage, but the relationships differ between conditions.

COPD

Smoking is the leading cause of chronic obstructive pulmonary disease (COPD), although not everyone with COPD has smoked.

COPD can cause persistent breathlessness, cough, sputum production and repeated exacerbations. Some people with COPD also develop Aspergillus-related disease, including CPA.

Stopping smoking is one of the most important ways to reduce further smoking-related damage, even when COPD is advanced.

For a fuller explanation, read COPD and Aspergillosis: Understanding the Connection.

Bronchiectasis

Bronchiectasis involves permanent widening and damage to parts of the airways, making mucus more difficult to clear.

It has many possible causes and should not automatically be described as a smoking-related illness. Nevertheless, smoking can add further irritation and interfere with normal airway defences.

People with bronchiectasis and aspergillosis may also need specialist advice about airway clearance and managing repeated infections.

Read Bronchiectasis and Aspergillosis for more information.

Asthma and ABPA

Smoking can make asthma harder to control and may reduce the effectiveness of some treatments.

Allergic bronchopulmonary aspergillosis (ABPA) is an allergic inflammatory condition involving Aspergillus, commonly affecting people with asthma or cystic fibrosis.

Smoking does not cause ABPA, but smoke exposure can add to airway irritation, wheezing and breathlessness.

If you have several respiratory diagnoses, it is important that new symptoms are assessed rather than automatically attributed to smoking or your existing aspergillosis.

Is it worth stopping after 30 or 40 years?

Yes.

Some lung damage, such as established emphysema or scarring, cannot be reversed simply by stopping smoking. However, stopping prevents further exposure to tobacco smoke and can slow the progression of smoking-related lung disease.

It also reduces the risks of cardiovascular disease, stroke and several cancers.

Some people notice less coughing or improved breathing after stopping. Others, particularly those with severe chronic lung disease, may experience less obvious changes.

The benefits are not limited to people who still have relatively healthy lungs.

Stopping smoking cannot guarantee that aspergillosis will improve, and it does not replace antifungal treatment or other respiratory care. It is one way of reducing additional harm.

Why can't I just stop?

Nicotine dependence is not simply a matter of willpower.

Nicotine affects reward pathways in the brain. When nicotine levels fall, withdrawal can cause cravings, irritability, restlessness, anxiety, difficulty concentrating and disturbed sleep.

Smoking also becomes linked to routines and emotions. A cigarette may be associated with a cup of tea, a break from work, an opportunity to sit down, or a way of coping with pain, stress or loneliness.

For someone living with chronic illness, these routines can become especially important.

It may help to identify what smoking provides beyond nicotine. For example, if a cigarette gives you permission to take a break, you may need to preserve that break even when you stop smoking.

Many people need several attempts before stopping permanently. Starting again after a period without cigarettes does not erase what you learned or mean that another attempt is pointless.

What help is available if I want to stop?

There are effective treatments for nicotine dependence, and you do not have to manage withdrawal symptoms alone.

Nicotine replacement therapy

Nicotine replacement therapy (NRT) includes patches, gum, lozenges, mouth sprays and inhalators.

These products provide nicotine without exposing your lungs to tobacco smoke. Using a patch alongside a faster-acting product for cravings is often more effective than relying on one product alone.

For people with significant lung disease, patches, gum and lozenges have the additional advantage of avoiding inhaled smoke or vaping aerosol.

Stop-smoking medicines

Prescription or pharmacy-supplied treatments may include varenicline, cytisine (cytisinicline) and, in appropriate circumstances, bupropion.

Availability and suitability vary. Your prescriber or pharmacist should consider your other health conditions and medicines before recommending treatment.

If you take antifungal medicines, corticosteroids or other long-term treatments, ask for an individual medication review. Do not assume that every stop-smoking treatment has the same interactions or precautions.

Behavioural support

Local NHS stop-smoking services can help you manage cravings, plan for difficult situations and choose appropriate treatments.

Support may be available through your GP practice, community pharmacy, local stop-smoking service or respiratory team.

See NHS Better Health – Quit Smoking.

What if I've switched from cigarettes to vaping?

This is an important distinction.

For adults who smoke, switching completely from tobacco cigarettes to nicotine vaping substantially reduces exposure to many harmful substances produced by burning tobacco.

Vaping is therefore not equivalent to smoking in terms of known health risks.

However, vaping is not harmless. The aerosol can contain substances that irritate the respiratory tract, and the long-term effects of vaping are not fully understood.

There is also relatively little direct research examining vaping specifically in people with CPA, ABPA, Aspergillus bronchitis or significant bronchiectasis.

If your lungs are already vulnerable, it is reasonable to ask whether inhaling any additional aerosol is desirable.

For someone who currently smokes, switching completely to nicotine vaping is generally less harmful than continuing to smoke cigarettes. For someone who does not smoke, starting to vape offers no health benefit.

If you have stopped smoking by switching to vaping, that is a meaningful reduction in tobacco-smoke exposure. You can discuss whether and when to reduce nicotine use further, without feeling pressured to make every change at once.

What if I both smoke and vape?

Some people use a vape in places where they cannot smoke but continue smoking cigarettes at other times.

This is often called dual use.

Although vaping may help some people move towards stopping cigarettes, continuing to smoke maintains substantial tobacco-related health risks.

Simply adding vaping to smoking is not equivalent to switching completely.

If your aim is to stop smoking, a stop-smoking adviser can help you develop a plan that addresses the cigarettes you find hardest to give up.

Nicotine replacement therapy is another option, particularly if you would prefer not to inhale vaping aerosol.

What about smoking cannabis?

Cannabis deserves particular attention because it raises two separate questions: the effects of inhaling cannabis smoke and the possibility of fungal contamination.

Some people use cannabis recreationally. Others use it in an attempt to manage pain, anxiety, poor sleep, appetite problems or the emotional burden of chronic illness.

Whatever the reason, it is important to understand the potential risks.

Cannabis smoke and damaged lungs

Smoking cannabis exposes the airways to smoke, fine particles and irritants.

Regular cannabis smoking is associated with symptoms such as cough, sputum production and bronchitic irritation. These effects may be particularly troublesome in people who already have asthma, COPD, bronchiectasis or aspergillosis.

Smoking cannabis mixed with tobacco also exposes the lungs to tobacco smoke and may contribute to nicotine dependence.

Evidence about the longer-term respiratory effects of cannabis is less complete than the evidence for tobacco. That uncertainty should not be interpreted as proof of safety.

Can cannabis contain Aspergillus?

Yes. Cannabis is plant material, and fungal contamination can occur during cultivation, drying, storage or handling.

Aspergillus species have been detected in cannabis products, and rare cases of serious fungal infection have been reported in association with cannabis use, particularly among people with substantially weakened immune systems.

However, these reports do not establish that cannabis commonly causes aspergillosis or that a particular person's infection came from cannabis.

The concern is especially relevant for people who are severely immunocompromised, including some transplant recipients and people receiving intensive immunosuppressive treatment.

Smoking or heating potentially contaminated plant material should not be assumed to eliminate fungal exposure.

For people with aspergillosis or significant lung disease, avoiding inhaled cannabis smoke is the safer respiratory choice.

Is vaping cannabis safer?

Cannabis vaping is not the same as using a regulated nicotine vape to stop smoking.

Cannabis oils, concentrates and vaping cartridges vary considerably in composition and quality. Some products may contain harmful additives, contaminants or solvents.

Serious acute lung injury has been associated with certain THC-containing vaping products, particularly illicit or informally sourced products containing vitamin E acetate.

Heating cannabis flower or concentrates also does not guarantee the absence of airway irritants or microbiological risks.

We do not have sufficient evidence to describe cannabis vaping as safe for people with aspergillosis, bronchiectasis or other significant respiratory disease.

Medicinal cannabis prescribed through a specialist service is a separate issue from unregulated products, but prescribed status does not automatically make an inhaled preparation appropriate for someone with damaged lungs. Discuss the route of administration and potential medicine interactions with the prescribing specialist.

What about smoking or inhaling other drugs?

Other recreational substances may also be smoked, heated or inhaled. Examples include crack cocaine and methamphetamine.

Depending on the substance and how it is used, risks can include airway irritation, acute lung injury, cardiovascular complications and serious breathing problems.

Some substances can also affect the heart, blood pressure, mental health or the way prescribed medicines are handled by the body.

For someone with existing lung damage, these additional risks can be particularly important.

There is no reliable basis for assuming that an inhaled recreational substance is safe simply because it does not contain tobacco.

If you use a substance regularly, or find it difficult to stop, confidential help is available through your GP or local drug and alcohol service.

For information and support, visit FRANK.

Could cannabis or other substances interact with my antifungal medicines?

Potential interactions deserve attention, particularly if you take medicines such as itraconazole, voriconazole, posaconazole or isavuconazole.

These antifungal medicines can affect liver enzymes involved in processing other substances. Some cannabis constituents, including THC and CBD, also use metabolic pathways that may be affected by medicines.

However, the size and clinical importance of a particular interaction depend on the product, dose, route of administration and the individual's other treatments.

We should not assume that all cannabis products interact in the same way or that a theoretical interaction will necessarily cause harm.

If you use cannabis, CBD products or other recreational substances, tell your pharmacist or prescribing clinician so that they can assess your individual medicines and circumstances.

You can also check the patient information leaflet for your prescribed medicine through the electronic Medicines Compendium.

Do not stop antifungal treatment or change doses yourself because of a suspected interaction.

What if I'm not ready to stop?

You can still take steps to protect your health.

Not everyone is ready to make a major change immediately, especially while managing breathlessness, fatigue, financial pressures or other difficult circumstances.

Possible first steps include:

  • Asking a pharmacist or stop-smoking adviser about treatment for nicotine cravings
  • Keeping your home and car free from tobacco smoke
  • Identifying situations that make you more likely to smoke
  • Discussing ways to stop using tobacco alongside cannabis
  • Avoiding shared smoking or vaping equipment
  • Avoiding unregulated vaping liquids or cartridges
  • Asking for support with drug or alcohol use without committing to an immediate change
  • Being open with your clinical team about what you inhale, particularly if symptoms have changed

Reducing smoking can be a step towards stopping, but smoking fewer cigarettes does not reliably remove the risks. The greatest health benefit comes from stopping tobacco smoking completely.

If you are dependent on another substance, professional support can help you consider safer ways forward.

What if I am worried about telling my doctor?

People sometimes avoid mentioning smoking, cannabis or other substances because they fear being blamed for their illness, refused treatment or reported to someone else.

Healthcare professionals need accurate information to understand symptoms, identify possible interactions and recommend appropriate care.

Medical information is normally treated confidentially, subject to limited legal and safeguarding exceptions. You can ask a clinician to explain confidentiality before discussing something sensitive.

You do not need to justify why you started using a substance or why you have found it difficult to stop.

You might say:

"There is something I use that might affect my lungs or medicines, but I've been reluctant to mention it. Could we talk about it privately?"

Or:

"I'm not ready to stop at the moment, but I'd like to understand the risks and what I can do to reduce them."

These are entirely reasonable questions to bring to a healthcare appointment.

When should I seek medical help?

Do not assume that a new respiratory symptom is simply caused by smoking, vaping or your existing aspergillosis.

Seek medical assessment if you develop a persistent change in cough, worsening breathlessness, increased sputum, fever, unexplained weight loss or persistent chest discomfort.

Coughing up blood requires particular care. Even a small amount of new blood should be assessed urgently. Call 999 if you cough up more than a few streaks or spots of blood, or if bleeding occurs with breathlessness, chest pain or feeling faint.

Sudden severe breathlessness, collapse, confusion or severe chest pain also requires emergency assessment.

Have a question you've been reluctant to ask?

Smoking, vaping, cannabis and recreational substances can be difficult subjects to discuss. You may have questions that were not answered during a hospital appointment, or you may want to hear how other people have approached similar difficulties.

Our Aspergillosis Discussion Community provides a place for patients and carers to ask questions, share experiences and continue conversations about living with aspergillosis.

Join the discussion: Smoking, Vaping and Aspergillosis →

You can ask a general question without identifying yourself or describing your own substance use.

Remember: Discourse is a community discussion space, not a confidential medical consultation. Posts may be visible to others. Avoid sharing personal medical details or information you would not want publicly associated with you.

For private advice about your own health, medicines or substance use, speak to your GP, respiratory team, pharmacist or a specialist support service.

The important thing to remember

Smoking and inhaling other substances can affect respiratory health, particularly when the lungs are already damaged.

But knowing something carries risks does not automatically make changing it easy.

Nicotine dependence, habits, stress, chronic pain and the challenges of living with a long-term condition can all make stopping difficult.

Whether you have already stopped smoking, switched to vaping, are thinking about making a change or are not ready yet, you deserve accurate information and appropriate healthcare.

You should be able to ask difficult questions without being judged for asking them.

Further information and support

More from The Questions We Don't Always Ask

This article provides general patient information and does not replace individual medical advice. Risks and treatment options depend on your medical history, respiratory condition and medicines. Seek advice from an appropriate healthcare professional before making changes to prescribed treatment.


Older woman sitting at a kitchen table eating vegetable soup with bread and salad

Too Breathless or Exhausted to Cook? Eating Well with Aspergillosis

Last reviewed: 21 October 2026
Audience: People living with aspergillosis, families and carers
Series: The Questions We Don't Always Ask

Older woman sitting at a kitchen table eating vegetable soup with bread and salad
Simple, nutritious meals can help people with aspergillosis eat well when breathlessness and fatigue make cooking difficult.

"I know I should eat properly, but by the time I've prepared something, I'm too exhausted to eat it." For people living with aspergillosis, preparing a meal can sometimes feel like an enormous task. Breathlessness, fatigue, pain, poor appetite and limited money can all make eating well more difficult. Fortunately, nutritious food doesn't have to mean complicated recipes, expensive ingredients or hours in the kitchen.

Key points

  • Preparing food can be physically demanding when you have chronic lung disease.
  • Simple meals, frozen ingredients and suitable ready meals can all contribute to good nutrition.
  • You do not need expensive equipment, specialist ingredients or cookbooks.
  • Eating enough protein and maintaining muscle strength may be particularly important when living with chronic illness.
  • Some patients need help losing weight, while others need additional nutrition to prevent unintended weight loss.
  • Small changes to how you shop, prepare and eat meals can conserve valuable energy.
  • Free recipes, NHS resources and practical support are available.

Why can cooking become so difficult?

Cooking involves considerably more activity than simply preparing food.

You may need to plan meals, shop, carry groceries, unpack them, stand while preparing ingredients, lift pans, cook, serve food and wash everything afterwards.

For someone with breathlessness or severe fatigue, these tasks can use much of the energy available for the day.

Other difficulties may include:

  • Feeling breathless when standing or moving around the kitchen.
  • Weakness, pain or stiffness affecting chopping and lifting.
  • Poor appetite, nausea or changes in taste.
  • Difficulty concentrating or remembering cooking instructions.
  • Feeling too tired to eat after preparing a meal.
  • Living alone without anyone to share cooking tasks.
  • Limited money for food, heating or electricity.

These are genuine practical barriers. They are not evidence of laziness or a lack of motivation.

Does aspergillosis affect nutrition?

Aspergillosis does not affect everyone's nutritional needs in the same way.

Some people with chronic pulmonary aspergillosis (CPA) experience poor appetite, unintended weight loss or loss of muscle mass. Others may gain weight because of reduced activity, corticosteroid treatment or associated health conditions.

People with allergic bronchopulmonary aspergillosis (ABPA), severe asthma or bronchiectasis may also find that breathlessness and fatigue interfere with everyday eating habits.

There is no single diet proven to treat aspergillosis itself. Good nutrition supports general health, but it does not replace antifungal treatment or other prescribed care.

If you are losing weight without trying, struggling to eat or becoming noticeably weaker, tell your clinical team. You may benefit from assessment by a dietitian.

Choose meals according to how much energy you have

One useful approach is to have different meal options for different days.

Rather than expecting yourself to cook properly every evening, think about what you can manage today.

Very difficult days: almost no preparation

On days when you are exhausted or breathless, a simple meal is better than going without food.

  • Yoghurt with fruit and cereal.
  • Wholegrain toast with peanut butter, cheese or another suitable topping.
  • Hummus with bread or crackers.
  • Tinned fish with bread or a ready-made salad.
  • Ready-to-eat soup with bread and cheese.
  • A suitable chilled or frozen ready meal.
  • Beans on toast, if you can manage a few minutes of heating.

These foods do not need to be expensive or elaborate. Supermarket own-brand products can be perfectly reasonable choices.

If your appetite is poor, smaller meals and snacks throughout the day may be easier than three large meals.

Days when you have a little energy

When you can manage some preparation, consider meals with only a few ingredients and minimal washing up.

  • Microwave rice with tinned beans and frozen vegetables.
  • Scrambled eggs with toast.
  • A jacket potato with beans, cheese or tuna.
  • Pasta with tomato sauce and tinned lentils.
  • An omelette with frozen or pre-prepared vegetables.
  • A simple sandwich with soup or fruit.

Prepared vegetables, frozen chopped onions and other convenient ingredients can reduce the effort needed.

Better days: prepare something for later

If you have a day when you feel stronger, preparing an extra portion may help you on a more difficult day.

Meals such as vegetable soup, lentil dishes, chilli and pasta sauces can often be prepared in larger quantities and frozen in individual portions.

However, batch cooking is only useful if it is manageable. You do not need to spend a good day exhausting yourself in the kitchen.

Cool cooked food promptly, refrigerate or freeze it safely, and follow NHS guidance on storage and reheating. Do not repeatedly reheat the same portion.

Make the kitchen work for you

Sometimes changing how you prepare food is as helpful as changing what you eat.

Occupational therapists and respiratory physiotherapists often recommend energy-conservation techniques for people living with long-term conditions.

Practical ways to save energy

  • Sit when possible: Prepare ingredients at a table rather than standing for long periods.
  • Keep things close: Store frequently used foods and utensils where they are easy to reach.
  • Use lightweight equipment: Avoid unnecessarily heavy pans and dishes.
  • Divide tasks: Prepare ingredients earlier and rest before cooking.
  • Reduce washing up: Choose one-pan meals or use the microwave where appropriate.
  • Accept convenient ingredients: Frozen, tinned and pre-prepared foods can save time and effort.
  • Ask for help: Shopping, carrying groceries or washing up may be tasks someone else can manage for you.

If breathlessness or limited mobility is making kitchen activities unsafe, ask your healthcare team about occupational therapy assessment or respiratory physiotherapy support.

Safety matters: If you use oxygen at home, follow your oxygen provider's fire-safety instructions. Oxygen equipment must be kept away from naked flames, gas hobs and other ignition sources as directed.

Eating well when money is tight

Chronic illness can reduce income while increasing household expenses. Some people also face higher heating costs, transport costs or difficulty shopping regularly.

Advice that assumes everyone can afford fresh fish, specialist foods or expensive kitchen equipment is not particularly helpful.

Fortunately, nutritious meals can be built around relatively inexpensive ingredients.

Affordable foods worth considering

  • Beans and lentils: Useful sources of protein and fibre, available dried or tinned.
  • Eggs: Versatile and relatively quick to prepare.
  • Frozen vegetables: Often economical, nutritious and less likely to be wasted.
  • Oats: Useful for porridge and other simple meals.
  • Potatoes, rice and pasta: Affordable foundations for meals.
  • Tinned fish: A convenient source of protein, where suitable for your diet.
  • Milk and yoghurt: Sources of protein and calcium, with fortified alternatives available.
  • Supermarket own-brand products: Often less expensive than branded equivalents.

Frozen and tinned foods are not automatically less healthy than fresh ingredients. Choose lower-salt or lower-sugar options where practical, but do not let the search for a perfect product prevent you from eating.

A ready meal may sometimes be cheaper and more manageable than buying numerous ingredients for a single serving.

If you are struggling to afford food, you can ask your GP practice, local council or Citizens Advice about available support, including local food assistance and benefits advice.

There is no shame in needing help with food costs.

What if I need to lose weight?

Some people with aspergillosis are overweight and may benefit from gradual weight loss.

However, trying to lose weight while managing fatigue and breathlessness can be particularly difficult.

It may help to focus on manageable changes rather than restrictive diets.

  • Consider portion sizes and how often you eat high-calorie snacks.
  • Choose filling meals containing protein and fibre.
  • Use frozen vegetables and other convenient ingredients to make meals easier.
  • Reduce sugary drinks if you consume them regularly.
  • Seek advice about appropriate activity from your respiratory team.

Preserving muscle strength is important, particularly for older adults and people with chronic lung disease.

For more information, see our article Weight and Aspergillosis: What If I'm Overweight and Struggling to Lose Weight?.

What if I am underweight or losing weight?

For other people, the challenge is getting enough food.

Chronic pulmonary aspergillosis can be associated with poor appetite, unintended weight loss and reduced muscle mass.

In this situation, advice to choose low-calorie foods or reduce portions may be inappropriate.

A dietitian may recommend more frequent meals, additional protein, energy-enriched foods or nutritional supplements, depending on your needs.

Possible approaches include:

  • Eating smaller meals more frequently.
  • Including protein-containing foods at meals and snacks.
  • Keeping convenient foods available for difficult days.
  • Choosing foods you enjoy and can manage to eat.
  • Discussing nausea, swallowing problems or persistent poor appetite with your healthcare team.

Unintended weight loss should not simply be accepted as a normal part of aspergillosis. It deserves assessment, particularly if it is new or progressing.

What if eating itself makes me breathless?

Some people find that large meals make breathing uncomfortable, particularly if they have significant respiratory disease.

Smaller, more frequent meals may be easier to manage.

Eating slowly, sitting upright and resting before meals may also help.

If you become breathless while eating, discuss this with your respiratory team. New or worsening breathlessness should not automatically be attributed to eating or weight.

Tell your clinician if you cough or choke when swallowing, experience food sticking, develop a wet-sounding voice after meals or have recurrent chest infections associated with eating. These symptoms may require a swallowing assessment.

Food hygiene and aspergillosis

Aspergillus is widespread in the environment, including soil, dust and decaying plant material.

However, pulmonary aspergillosis is generally associated with inhalation of airborne spores rather than eating ordinary food.

Most people with aspergillosis do not need to follow a special mould-free diet.

Standard food hygiene remains important:

  • Follow use-by dates and storage instructions.
  • Keep chilled foods refrigerated.
  • Cook foods thoroughly where required.
  • Wash hands and food preparation surfaces.
  • Discard visibly mouldy perishable foods rather than simply removing the mouldy area.
  • Store leftovers safely and reheat according to NHS food-safety guidance.

People who are severely immunocompromised, such as some transplant recipients or patients receiving intensive cancer treatment, may need additional food-safety precautions. Their specialist team should provide individual advice.

There is no need to impose restrictive food rules on everyone with aspergillosis.

Useful free cooking and nutrition resources

You do not need to purchase a cookbook to find practical ideas. Several organisations provide free advice and accessible recipes.

NHS: Eating Well with Fatigue

The Northern Care Alliance NHS provides practical advice about maintaining nutrition when fatigue makes shopping, preparing and eating meals difficult.

This is particularly relevant for people who find that ordinary kitchen tasks use too much energy.

Read Eating Well with Fatigue – Northern Care Alliance NHS

NHS Healthier Families recipes

The NHS offers free recipes for everyday meals, including relatively simple family dishes.

These may be useful when you have enough energy to cook and want ideas using familiar ingredients.

Explore NHS Healthier Families recipes

Care to Cook

Care to Cook offers accessible recipes and cooking resources designed to make food preparation easier to understand and manage.

The straightforward instructions may be particularly helpful for people who find complicated recipes tiring or difficult to follow.

Explore Care to Cook accessible recipes

The Sad Bastard Cookbook

This freely available cookbook by Rachel A. Rosen and Zilla Novikov takes an unusually practical approach to cooking when energy, motivation or concentration are very limited.

It includes ideas requiring little preparation and commonly available ingredients.

The language and humour are deliberately irreverent, so it may not suit everyone. However, its central message is valuable: eating something manageable is better than feeling defeated by the expectation of preparing a perfect meal.

Find The Sad Bastard Cookbook (free download; check the provider's current terms).

Optional further reading: Cookfulness

Cookfulness, developed by Ian Taverner, explores cooking while living with pain, fatigue, disability and other long-term health difficulties.

Its approach recognises that cooking can be physically and mentally demanding and that recipes may need adapting to the person preparing them.

Some Cookfulness resources and publications are commercial. They are entirely optional; there is no need to purchase anything to follow the advice in this article.

Explore Cookfulness

What if I cannot manage cooking at all?

There may be times when cooking is simply not possible.

If this happens regularly, it is worth discussing with your GP, specialist nurse or another member of your healthcare team.

Depending on your circumstances, support might include:

  • Dietetic assessment.
  • Occupational therapy advice about kitchen adaptations.
  • Social care assessment for help with daily living.
  • Support with shopping or meal preparation.
  • Community meal services, where available.
  • Advice about benefits or financial assistance.

If you are unable to obtain or prepare enough food, this is a health and wellbeing concern, not simply a lifestyle preference.

Ask for help before the situation leads to significant weight loss, dehydration or worsening weakness.

The question worth asking

Instead of asking, "Why can't I manage to cook properly?", perhaps the more useful question is:

"What is the simplest way I can eat well with the energy, money and support I have available?"

For some people, that will mean cooking from scratch. For others, it may mean a microwave meal, beans on toast, a prepared sandwich or help from someone else.

Good nutrition is not a competition, and there is no prize for making everything yourself.

Eating well should support your health, not leave you exhausted.

Further information

Medical information: This article provides general educational information. Nutritional needs vary according to your health, medicines and circumstances. If you are losing weight unintentionally, struggling to eat or have specific dietary restrictions, seek individual advice from your healthcare team or a registered dietitian.

More from The Questions We Don't Always Ask

Living with aspergillosis affects more than your lungs. Explore other everyday health questions in our patient information series.


Woman sitting at a kitchen table with a nutritious meal of soup, salad and wholegrain bread

Weight and Aspergillosis: What If I'm Overweight and Struggling to Lose Weight?

Last reviewed: 21 October 2026
Audience: People living with aspergillosis, families and carers
Series: The Questions We Don't Always Ask

Woman sitting at a kitchen table with a nutritious meal of soup, salad and wholegrain bread
Managing weight with aspergillosis can be challenging when fatigue, breathlessness and treatment affect everyday life.

"I know I need to lose weight, but I can barely manage the stairs. How am I supposed to exercise?" For people living with aspergillosis, weight can be a particularly difficult subject. Breathlessness, fatigue, steroid treatment and reduced activity may all make managing weight harder. This article looks at what can help, without blame, unrealistic expectations or one-size-fits-all advice.

Key points

  • Weight is influenced by many factors, including biology, medicines, sleep, health conditions and circumstances. It is not simply a question of willpower.
  • Excess body weight can increase the effort needed to breathe and may worsen breathlessness, but it does not explain every respiratory symptom.
  • Steroid treatment, reduced mobility and disrupted sleep can make weight management more difficult.
  • Preserving muscle, strength and adequate nutrition is particularly important for people with chronic lung disease.
  • Even modest, sustained weight loss may improve some aspects of health, but the right goal varies between individuals.
  • Dietetic advice, respiratory physiotherapy, pulmonary rehabilitation and specialist weight management support may help.
  • Some people with aspergillosis need nutritional support to prevent weight loss rather than advice to lose weight.

Why is weight such a difficult subject?

Many people who are overweight already know the standard advice: eat less and move more.

What they may not have been given is a realistic explanation of how to do that while living with a chronic illness.

Someone with aspergillosis may experience breathlessness when walking, exhaustion after ordinary activities, disturbed sleep, repeated infections or prolonged courses of treatment.

Preparing meals, shopping and exercising may all require more effort than they once did.

Some people also feel embarrassed about their weight or worry that healthcare professionals will attribute every symptom to it.

These concerns matter. People should be able to discuss weight without feeling blamed or having their lung disease overlooked.

Does being overweight make aspergillosis worse?

There is limited direct research showing how obesity affects the progression of different forms of aspergillosis, such as chronic pulmonary aspergillosis (CPA) or allergic bronchopulmonary aspergillosis (ABPA).

However, excess body weight can affect breathing and general health in several ways.

  • Breathing effort: Extra weight around the chest and abdomen can make breathing more physically demanding.
  • Exercise tolerance: Walking and climbing stairs may require more energy, particularly when lung function is already reduced.
  • Sleep: Obesity increases the risk of obstructive sleep apnoea, which can cause poor sleep and daytime tiredness.
  • Other conditions: Obesity is associated with increased risks of type 2 diabetes, cardiovascular disease and high blood pressure.
  • Asthma: Obesity can contribute to poorer asthma control in some people, potentially adding to respiratory symptoms in patients with ABPA or severe asthma.

But an important distinction is needed: being overweight does not mean that breathlessness, coughing, fatigue or worsening lung function should automatically be blamed on weight.

New or worsening symptoms may require investigation for infection, changes in aspergillosis, asthma, bronchiectasis or other medical problems.

Why can aspergillosis make weight management harder?

Breathlessness and reduced activity

When ordinary activity causes breathlessness, people naturally begin to avoid unnecessary exertion.

Over time, reduced activity can lead to loss of muscle strength and physical conditioning. Everyday tasks then require more effort, which can make breathlessness feel worse.

This creates a difficult cycle: breathing problems reduce activity, reduced activity lowers fitness, and lower fitness makes activity harder.

Breaking that cycle may require supervised rehabilitation rather than simply being told to exercise more.

Fatigue and poor sleep

Chronic fatigue can affect motivation, meal preparation and daily routines. Poor sleep may also influence appetite and eating behaviour.

People who are exhausted may rely more heavily on convenient foods, not because they lack knowledge, but because they have limited energy.

If you snore heavily, wake gasping, have morning headaches or experience marked daytime sleepiness, ask your GP whether assessment for sleep apnoea is appropriate.

Steroid treatment

Some people with ABPA or severe asthma require oral corticosteroids such as prednisolone or methylprednisolone.

These medicines can increase appetite, alter fat distribution and contribute to fluid retention. Longer-term treatment can also affect blood glucose and muscle strength.

Weight changes during steroid treatment are therefore not always explained by changes in eating habits alone.

Do not stop or reduce prescribed corticosteroids to control weight without medical advice. Steroid doses may need careful adjustment, and abrupt withdrawal can be dangerous, particularly after prolonged treatment.

If weight gain is becoming a significant problem, ask whether your treatment and steroid exposure can be reviewed safely.

What about people with CPA who are losing weight?

This is an especially important distinction.

Some people with chronic pulmonary aspergillosis experience unintended weight loss, reduced appetite, poor nutrition or loss of muscle mass.

For these patients, trying to lose more weight may be inappropriate or harmful, even if their body mass index appears to be above the conventional healthy range.

Muscle strength and nutritional status can matter as much as the number on the scales.

If you have been losing weight without trying, have a poor appetite or notice increasing weakness, tell your clinical team. A dietitian may be able to help you maintain weight, improve protein intake and preserve muscle.

The aim is not to make everyone with aspergillosis thinner. It is to support better health, strength and daily functioning.

How do I know whether my weight is affecting my health?

Body mass index (BMI) is a commonly used measure based on height and weight.

For many adults, a BMI of 25 to 29.9 is classified as overweight, while 30 or above is classified as obesity. Different risk thresholds apply to some ethnic groups.

However, BMI is only one part of a health assessment. It does not directly measure muscle mass, fat distribution, fitness or nutritional health.

Waist measurement, blood pressure, blood glucose, cholesterol, muscle strength and other medical conditions may provide additional information.

For older adults, particularly those with chronic illness, weight goals should also take account of muscle preservation and functional ability.

Ask your GP or dietitian what a sensible target would be for you, rather than relying entirely on a BMI chart.

What if I cannot exercise because I am breathless?

This is one of the most understandable frustrations for people with chronic lung disease.

Exercise does not have to mean running, going to a gym or pushing yourself until you are exhausted.

For some people, carefully supervised walking, chair-based exercises or light resistance work may be a more appropriate starting point.

But the right activity depends on the stability and severity of your lung disease.

Respiratory physiotherapy and pulmonary rehabilitation

Pulmonary rehabilitation combines individually assessed exercise with education and support for people living with chronic respiratory conditions.

A respiratory physiotherapist can help identify appropriate activities, assess breathlessness and develop a programme that takes account of your lung disease, fitness and other medical problems.

This is particularly important if you have severe asthma, significant oxygen desaturation, haemoptysis (coughing up blood), advanced lung disease or a history of complications during exertion.

Do not begin a strenuous exercise programme without specialist advice if you have significant respiratory symptoms or a history of haemoptysis. Active bleeding or sudden worsening of breathlessness requires medical assessment rather than exercise.

For some people, the first goal may be to maintain mobility or regain confidence rather than lose weight.

Can I lose weight without doing much exercise?

Yes. Changes in food intake can contribute to weight loss even when physical activity is limited.

However, reducing food intake too aggressively can also lead to muscle loss, weakness and nutritional deficiencies.

For someone with chronic lung disease, the aim should generally be gradual, sustainable change while maintaining adequate protein and other essential nutrients.

Possible starting points include:

  • Reviewing portion sizes without skipping nutritious meals.
  • Reducing sugary drinks or frequently consumed high-calorie snacks.
  • Including protein-containing foods as part of regular meals.
  • Choosing foods that are convenient to prepare when fatigue is a problem.
  • Planning meals around your energy levels rather than expecting complicated cooking every day.
  • Asking for dietetic support if you have several medical conditions or are unsure how to balance weight loss with adequate nutrition.

Very restrictive diets, prolonged fasting and rapid weight-loss plans may be unsuitable for some people with chronic illness.

If you have diabetes, kidney disease, poor nutritional status or take medicines affected by food intake, seek individual advice before making substantial dietary changes.

What if I am too exhausted or breathless to cook?

Eating well can be particularly difficult when you have chronic lung disease. Shopping, preparing ingredients, standing at the cooker and washing up may use more energy than you have available.

It is not necessary to prepare every meal from scratch. Frozen vegetables, tinned beans, prepared ingredients, microwave rice and suitable ready meals can all be part of a nutritious diet.

Some practical approaches include:

  • On difficult days: Choose simple meals that require little preparation, such as eggs on toast, soup with bread and cheese, or yoghurt with fruit.
  • When you have some energy: Try one-pan meals, microwave cooking or prepared ingredients that reduce chopping and washing up.
  • On better days: Consider preparing extra portions and freezing them for later, if you can do so safely.
  • Make cooking easier: Sit while preparing food, keep frequently used items within reach and take breaks when needed.

If you are trying to lose weight, portion sizes and nutritional balance still matter. If you are losing weight unintentionally or struggling to maintain muscle, you may need more energy and protein instead. A dietitian can help you identify what is appropriate.

Two useful resources are:

Remember: A simple, manageable meal is often more useful than an elaborate healthy recipe that leaves you exhausted.

Would losing a small amount of weight make a difference?

For some people living with obesity, modest weight loss can improve blood pressure, blood glucose control, mobility or other aspects of health.

Whether it improves breathlessness depends on what is causing that breathlessness. Weight loss cannot reverse lung damage caused by aspergillosis.

It is reasonable to set goals based on things that matter to you, such as:

  • Being able to walk a little further.
  • Finding everyday activities less exhausting.
  • Improving blood glucose or blood pressure.
  • Sleeping better.
  • Maintaining muscle strength.
  • Feeling more comfortable and confident.

Progress may be slow, and there may be periods when maintaining your weight is a worthwhile achievement.

What about weight-loss injections such as Wegovy or Mounjaro?

Medicines used to treat obesity, including semaglutide (Wegovy) and tirzepatide (Mounjaro), can help eligible people lose weight by affecting appetite and feelings of fullness.

They are not suitable for everyone and are not treatments for aspergillosis itself.

Access through the NHS depends on clinical eligibility, local services and the phased introduction of some treatments.

These medicines may cause side effects such as nausea, vomiting, diarrhoea or constipation. For someone already struggling with appetite, hydration, nutrition or maintaining muscle, these effects deserve particular attention.

People taking antifungal medicines or several other treatments should have their complete medication list reviewed before starting weight-management medication.

Some medicines affect stomach emptying, and gastrointestinal side effects can make it harder to take or tolerate other prescribed treatments. The clinical significance depends on the medicines involved.

Do not assume that weight-loss injections are appropriate simply because your BMI is above a particular threshold. A clinician should assess your overall health, nutrition, treatment and eligibility.

For current NHS guidance, see NHS England: Weight management injections.

What if I have tried to lose weight many times?

Repeated attempts at weight loss can be discouraging, especially when weight returns after an initial improvement.

Obesity is a complex, long-term health condition. Appetite regulation, metabolism, medicines, environment and personal circumstances can all influence weight.

Regaining weight does not mean that someone has failed or that previous efforts were pointless.

If you have repeatedly struggled, structured support may be more useful than another short-term diet.

Your GP may be able to discuss community weight-management programmes, dietetic support, specialist services or medical treatments where appropriate.

What if I feel judged about my weight?

People living with obesity sometimes report that their symptoms are dismissed or attributed to their weight before other causes are properly investigated.

This can be particularly concerning when someone already has a diagnosed respiratory condition.

It is entirely reasonable to ask for both issues to be considered.

"I understand my weight may contribute to my breathlessness, but I also have aspergillosis. Can we check whether my lung condition is stable and discuss what support might help me manage my weight?"

You deserve appropriate investigation and treatment for your respiratory symptoms regardless of your weight.

Where should I start?

Rather than beginning with an ambitious target, consider asking three questions:

  • Is weight loss appropriate for me? Or should I prioritise maintaining weight, improving nutrition or rebuilding muscle?
  • What is making weight management difficult? Steroids, fatigue, poor sleep, breathlessness, emotional stress or something else?
  • What support would make a realistic difference? A dietitian, respiratory physiotherapist, pulmonary rehabilitation, weight-management service or medication review?

These questions can turn a difficult subject into a practical conversation with your healthcare team.

The question worth asking

Instead of asking, "Why can't I just lose weight?", try asking:

"What would help me become healthier and stronger, given the limitations of my lung disease?"

For some people, the answer will include gradual weight loss. For others, it may be improved nutrition, greater muscle strength, better sleep or more effective management of their respiratory condition.

All of these are legitimate health goals.

Where to find reliable information

Medical information: Weight-management advice should be adapted to your medical history, nutritional status and prescribed treatments. This article provides general educational information and does not replace individual advice from your GP, respiratory specialist, dietitian or physiotherapist.

Struggling to prepare meals? Read our guide Too Breathless or Exhausted to Cook? Eating Well with Aspergillosis for affordable meal ideas, energy-saving cooking tips and free resources.